The invention relates to the fields of pharmacology, and provides metabolic supplement formulations and methods for the treatment of depression and anxiety. The metabolic supplement formulation comprises a combination of a vitamin B6 compound, a vitamin B12 compound, a folate, a betaine, N-acetyl-L-tyrosine, and a pharmaceutically acceptable carrier.
